MARKET

ADXN

ADXN

Addex Therapeutics Ltd
NASDAQ
1.190
+0.090
+8.18%
Closed 16:00 03/20 EDT
OPEN
1.140
PREV CLOSE
1.100
HIGH
1.280
LOW
1.130
VOLUME
135.31K
TURNOVER
95.57K
52 WEEK HIGH
5.45
52 WEEK LOW
0.5500
MARKET CAP
15.30M
P/E (TTM)
-0.3300
1D
5D
1M
3M
1Y
5Y
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 3d ago
ThermoGenesis, Elevation top healthcare gainers; VolitionRx, InfuSystem among losers
Seeking Alpha · 5d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 5d ago
PaxMedica, Avid Bioservices top healthcare gainers; Rapt, Unicycive lead losers' pack
Seeking Alpha · 6d ago
TFC, NYCB and KEY are among pre market gainers
Seeking Alpha · 6d ago
Why Barnes & Noble Education Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket
Benzinga · 03/10 13:03
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga · 03/06 18:25
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 03/01 21:31
More
About ADXN
Addex Therapeutics Ltd is a Switzerland-based clinical-stage pharmaceutical company. The Company focuses on development and commercialization of orally available small molecule drugs known as allosteric modulators for neurological disorders. The Company’s clinical programs pipeline include dipraglurant (mGlu5 NAM), which is Phase 2a placebo-controlled clinical trial for Parkinson's disease levodopa-induced dyskinesia (PD-LID), and is being prepared to enter registration trials for PD-LID, and ADX71149 (mGlu2 positive allosteric modulator or PAM), which is being developed in collaboration by its partner Janssen Pharmaceuticals, Inc to treat schizophrenia and anxious depression. It also is advancing several preclinical programs, including GABABPAM for pain, overactive bladder and other disorders, mGlu7 NAM for post-traumatic stress disorder, mGlu2 NAM for mild neurocognitive disorders, mGlu4 PAM for Parkinson’s disease and mGlu3 PAM for neurodegenerative disorders.

Webull offers kinds of Addex Therapeutics Ltd - ADR stock information, including NASDAQ:ADXN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADXN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ADXN stock methods without spending real money on the virtual paper trading platform.